Genprex receives IRB approval for NSCLC gene therapy trial; shares up 4%
May 05 2021 - 9:21AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Genprex (NASDAQ:GNPX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Genprex (NASDAQ:GNPX)
Historical Stock Chart
From Sep 2023 to Sep 2024